Search
Research
TLR2 mediates recognition of live staphylococus epidermidisStaphylococcus epidermidis is a nosocomial pathogen that causes catheter-associated bacteremia in the immunocompromised, including those at the extremes of age
Research
Birthweight and the risk of childhood-onset type 1 diabetesWe investigated whether children who are heavier at birth have an increased risk of type 1 diabetes
Research
Start Stronger, Live Longer National Aboriginal Health Worker Symposium: Final ReportThe Rio Tinto Aboriginal Health Partnership marries Rio Tinto's commitment and dedication to community investment with research expertise of the Telethon Inst
Research
Adult psychosocial outcomes of children with specific language impairment, pragmatic language impairment and autismEvidence that some children also develop autistic symptomatology over time has raised suggestions that developmental language disorder...
Research
Investigating genotype-phenotype relationships in Rett syndrome using an international data setThis study uses data from a large international database, InterRett, to examine genotype-phenotype relationships and compares these with previous findings in...
Research
The common BDNF polymorphism may be a modifier of disease severity in Rett syndromeRett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MECP2).
Research
Siblings of children with disabilities: challenges and opportunitiesSiblings of children with disabilities: challenges and opportunities
Research
Late language emergence at 24 months: an epidemiological study of prevalence, predictors, and covariatesThe primary objectives of this study were to determine the prevalence of late language emergence (LLE) and to investigate the predictive status of maternal...
Research
Investigations into the role of ST2 in acute asthma in childrenThis study investigated the potential role of ST2 in children with acute asthma.
Research
Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapyTopical application of tumors with the TLR7 agonist imiquimod is an effective adjunct treatment for a range of primary dermatological cancers.